Granges, Switzerland

Arnaud Perilleux

This inventor holds 1 USPTO granted patent, plus 1 CIPO patent. Top assignee: Ares Trading S.a.. Active years: 2018.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Arnaud Perilleux. Retrieved from https://idiyas.com/inventor/arnaud-perilleux

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0


Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2018

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Arnaud Perilleux: Innovator in High-Performance Mammalian Cultures

Introduction: Arnaud Perilleux, a prominent inventor based in Granges (Veveyse), Switzerland, has made significant contributions to the field of biotechnology. With a strong focus on developing serum- and protein-free culture media, his innovative work plays a crucial role in enhancing mammalian fed-batch cultures.

Latest Patents: Arnaud holds one patent titled "Medium for High Performance Mammalian Fed-Batch Cultures." This invention involves novel culture media designed to optimize the growth conditions for mammalian cells. The patent outlines methods for both preparing and utilizing these culture media, marking a notable advancement in biotechnological applications.

Career Highlights: Currently, Arnaud is employed at Ares Trading S.a., where he applies his expertise towards improving biotechnological processes. His work has potential implications for various industrial applications, particularly in the pharmaceutical and research sectors.

Collaborations: Arnaud collaborates with talented individuals such as Herve Broly and Matthieu Stettler. Together, they contribute to the innovative endeavors within their organization, fostering a productive environment that encourages the development of cutting-edge biotechnological solutions.

Conclusion: Arnaud Perilleux stands out as a key player in the field of biotechnology through his inventive approaches to culture media. His patent serves as a testament to his commitment to innovation, benefiting the broader scientific community and enhancing the capabilities within mammalian cell culture practices.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…